EC grants CMA to Janssen's Talvey for multiple myeloma : vim

EC grants CMA to Janssen's Talvey for multiple myeloma

The European Commission (EC) has granted conditional marketing authorisation (CMA) to the Janssen Pharmaceutical Companies of Johnson & Johnson’s Talvey.

Related Keywords

Peter Lebowitz , Drug Administration , Janssen Research Development Oncology , Development Oncology ,

© 2025 Vimarsana